CHE vs USB · P/E 24, rev $2.43B vs P/E 12, rev $28.66B
Chemed Corp (CHE) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the CHE and USB stock pages for the full models.
Not investment advice.